Dexamethasone premedication suppresses vaccine-induced immune responses against cancer
Glucocorticosteroids (GCS) have an established role in oncology and are administered to cancer patients in routine clinical care and in drug development trials as co-medication. Given their strong immune-suppressive activity, GCS may interfere with immune-oncology drugs. We are developing a therapeu...
Main Authors: | Mathias Vormehr, Sophie Lehar, Lena M. Kranz, Siri Tahtinen, Yoko Oei, Vincent Javinal, Lélia Delamarre, Kerstin C. Walzer, Mustafa Diken, Sebastian Kreiter, Ira Mellman, Ugur Sahin, Jill M. Schartner, Özlem Türeci |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-01-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2020.1758004 |
Similar Items
-
A liposomal RNA vaccine inducing neoantigen-specific CD4+ T cells augments the antitumor activity of local radiotherapy in mice
by: Nadja Salomon, et al.
Published: (2020-01-01) -
Recovery from rocuronium with sugammadex in children premedicated with dexamethasone for prevention of postoperative nausea and vomiting
by: Rabab Saber Saleh, et al.
Published: (2017-01-01) -
Comparison of the Premedication Effect of Propofol and Dexamethasone on Reducing Fentanyl-Induced Cough
by: Reihanak Talakoub, et al.
Published: (2018-05-01) -
Investigation of the Effects of Spinal Dexamethasone Injection as a Premedication in Rabbit Anesthesia
by: H. Hejazi, et al.
Published: (2019-03-01) -
Dendritic Cell-Targeted Vaccines
by: Lelia eDelamarre, et al.
Published: (2014-05-01)